Neutrophil-avid nanocarrier uptake by STAT3 dominant-negative hyper-IgE syndrome patient neutrophils is a research paper published in Life Science Alliance (2024). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
HHS | National Institutes of Health
Grant: F32 HL151026, L40 HL159788
HHS | National Institutes of Health
Grant: F32 HL162425, 5T32 HL007586-35, KL2TR001879
HHS | National Institutes of Health
Grant: R01HL151467, R01 HL158737, R01 HL141462, R41 HL156767, U01 HL131022
DOD | USA | MEDCOM | Congressionally Directed Medical Research Programs
Grant: W81XWH2210503
NHLBI NIH HHS
Grant: F32 HL151026
NHLBI NIH HHS
Grant: R41 HL156767
NHLBI NIH HHS
Grant: R01 HL158737
NHLBI NIH HHS
Grant: U01 HL131022
NHLBI NIH HHS
Grant: F32 HL162425
NCATS NIH HHS
Grant: KL2 TR001879
NHLBI NIH HHS
Grant: L40 HL159788
NHLBI NIH HHS
Grant: R01 HL151467
NHLBI NIH HHS
Grant: T32 HL007586
NHLBI NIH HHS
Grant: R01 HL141462
National Institutes of Health
Grant: 1R01HL151467-01
mTOR signaling in lung homeostasis, aging and disease
National Institutes of Health
Grant: 1F32HL151026-01
Development of Neutrophil-Avid Nanocarriers as an Antibiotic Delivery System
National Institutes of Health
Grant: 5KL2TR001879-04
Institutional Clinical and Translational Science Award
National Institutes of Health
Grant: 1R41HL156767-01A1
Nitazoxanide as a Novel Therapy for Rare Disease Lymphangioleiomyomatosis and Tuberous Sclerosis
National Institutes of Health
Grant: 5R01HL158737-02
mTORC1 and WNT in lung mesenchyme
National Institutes of Health
Grant: 5U01HL131022-08
The Molecular and Genetic Pathogenesis of LAM
National Institutes of Health
Grant: 5R01HL141462-02
Urokinase-type plasminogen activator (uPA) in pathogenesis of lymphangioleiomyomatosis (LAM)
National Institutes of Health
Grant: 1F32HL162425-01
Pulmonary Endothelial-Mesenchymal Crosstalk in Hyperactive mTOR Lung Diseases
National Institutes of Health
Grant: 5T32HL007586-22
Training in Pulmonary Immunology
Fields of Study
MeSH Terms
Keywords